Pharmacotherapy of large B-cell lymphoma

Author： Escalón Maricer P Lossos Izidore S

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.13, 2008-09, pp. : 2247-2258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni DeJoubner Nutan Flowers Christopher

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Methotrexate: EBV-associated large B-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Methotrexate: Diffuse large B-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Methotrexate: Diffuse large B-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1180, 2007-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Efalizumab: Diffuse large B-cell lymphoma: case report

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite